MRM

Medirom Healthcare Technologies Inc. MRM

NasdaqSmall CapConsumer Discretionary

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 8 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Revenue

$8.30B

Quarter to Dec 31

Net income

$148.76M

Quarter to Dec 31

Free cash flow

$-1.40B

Quarter to Dec 31

Operating margin

-0.2%

Quarter to Dec 31

Top Institutional Holders

as of Q2 2026
$176.1K total
CITADEL ADVISORS LLC
$57.8KNew
HRT FINANCIAL LP
$56.0K+359.9%
UBS Group AG
$28.0K+2.4%
Virtu Financial LLC
$16.0KNew
TWO SIGMA SECURITIES, LLC
$10.9K-24.4%
GAMMA Investing LLC
$3.9K-40.7%
RHUMBLINE ADVISERS
$3.2K+56.5%
SRS Capital Advisors, Inc.
$309New
See all 8 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

FY 2024
EDGAR

Net Income

FY 2024
EDGAR

EPS (Diluted)

FY 2024
EDGAR

Operating Margin

FY 2024
EDGAR

ROIC

FY 2024
EDGAR

Free Cash Flow

FY 2024
EDGAR

Debt/Equity

FY 2024
EDGAR

Loading ratio trend…

MRM key financials by period

Reported revenue, net income and operating margin by fiscal year, from Medirom Healthcare Technologies Inc.'s annual filings on SEC EDGAR.

Medirom Healthcare Technologies Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2024$8.3B$148.8M-0.2%
FY 2023$6.8B$115.4M-5.7%
FY 2022$7.0B$149.0M1.4%
FY 2021$5.4B$-990.7M-8.7%
FY 2020$3.3B$-539.2M-22.3%
FY 2019$3.9B$17.3M0.9%
Source: MRM filings on SEC EDGAR →

MRM insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Medirom Healthcare Technologies Inc. (MRM): stock profile, AI score and financials

Medirom Healthcare Technologies Inc. (MRM) stock profile, AI quality score, and SEC EDGAR financial data, a Consumer Discretionary sector company. MRM is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 8 institutional filers currently hold this stock. Based on the latest XBRL financial filings (FY 2024), Medirom Healthcare Technologies Inc. reports quarterly revenue of $8.3B, net income of $148.8M, an operating margin of -0.2%. Top institutional holders of MRM by reported 13-F value include CITADEL ADVISORS, HRT FINANCIAL, UBS Group AG, based on the most recent SEC filings. MRM trades on the Nasdaq exchange and files with the SEC under CIK 1819704. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MRM daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Medirom Healthcare Technologies Inc. directly from SEC EDGAR.

SEC EDGAR: CIK 1819704 →